Over the past few years there have been several exciting drug developments for use in veterinary patients that are specifically marketed for the treatment of neoplastic disease. These have largely arisen due to an increased understanding of the science behind cancer development and treatment, such as...
Some 4 million dogs in the U.S. are diagnosed with cancer every year, often the same kinds humans get. And since we share many of the same genes with our canine companions, dogs with naturally developing cancers are being enrolled in clinical trials, with doctors and scientists using what ...
Like people, not all dogs respond the same way to an anticancer drug. That’s why we provide you with true precision medicine. By analyzing your dog's live cancer cells with the most powerful biotechnologies available, we provide you with predictions that apply specifically to the patient at ...
Cancer vaccines have garnered attention as a potential treatment for cancer metastases. Nevertheless, the clinical response rate to vaccines remains < 30%. Nanoparticles stabilize vaccines and improve antigen recognition and presentation, resulting in high tumor penetration or accumulation, effective co...
Furthermore, the use of hormones has been shown to be accompanied by serious side effects, for example a high risk of pyometra, cancer of the mammary gland, and induction of diabetes mellitus in prediabetic patients.It is common medical practice that methods with serious side-effects that are...
Feasibility of this approach is supported by results in animal models including rodents, pigs, goats, bulls, dogs, and monkeys. However, transplantation of cryopreserved testis cells isolated from patients with cancer carries an inherent risk of reintroducing contaminating malignant cells back into ...
Ovarian cancer is a prevalent gynecologic malignancy with the second-highest mortality rate among gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for ovarian cancer; however, a majority of patients with ovarian cancer ex
Owing to patient-derived tumor tissues and cells, significant advances have been made in personalized cancer treatment and precision medicine, with cancer stem cell-derived three-dimensional tumor organoids serving as crucial in vitro models that accurat
Provided herein are therapies including dosage regimens for the treatment of cancer using B-RAF and an immune checkpoint inhibitor in combination with and/or without a MEK inhibitor
Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K.T-oligo induces apoptosis in advanced prostate cancer cells. Oligonucleotides. Sep. 2009;19(3):287-92. doi: 10.1089/o1i.2009.0179. PubMed PMID: 19642913—Exhibit 9 (provided concurrently by US mail). ...